Who owns Viking Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VKTX from SEC Form 13F filings across 442 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 442 institutions disclosed 81.4M shares of Viking Therapeutics, Inc. worth $2.66B — about 69% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
442
13F holders
$2.66B
value, 2026 filers
69%
of shares outstanding (81.4M sh)
83
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of VKTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 9.8M | $321.0M | 0.0% | 8.3% | +55.4% |
| 2 | BlackRock, Inc. | 6.2M | $201.0M | 0.0% | 5.2% | -0.4% |
| 3 | STATE STREET CORP | 5.5M | $180.8M | 0.0% | 4.7% | -1.1% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 5.4M | $175.9M | 0.0% | 4.6% | +6.7% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.7M | $153.8M | 0.0% | 4% | +5.2% |
| 6 | MORGAN STANLEY | 3.6M | $116.7M | 0.0% | 3% | +2.7% |
| 7 | TWO SIGMA INVESTMENTS, LP | 2.4M | $78.3M | 0.1% | 2% | -39.0% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $71.8M | 0.0% | 1.9% | +5.0% |
| 9 | CITADEL ADVISORS LLC | 1.9M | $60.6M | 0.0% | 1.6% | +95.4% |
| 10 | AMERICAN CENTURY COMPANIES INC | 1.6M | $53.1M | 0.0% | 1.4% | -10.4% |
| 11 | AQR CAPITAL MANAGEMENT LLC | 1.3M | $41.7M | 0.0% | 1.1% | +552.9% |
| 12 | UBS Group AG | 1.1M | $34.8M | 0.0% | 0.9% | +14.0% |
| 13 | BNP PARIBAS FINANCIAL MARKETS | 1.1M | $34.7M | 0.0% | 0.9% | +8.5% |
| 14 | Woodline Partners LP | 1.0M | $34.0M | 0.1% | 0.9% | +244.5% |
| 15 | ADAR1 Capital Management, LLC | 1.0M | $33.7M | 1.5% | 0.9% | +80.3% |
| 16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.0M | $33.5M | 0.0% | 0.9% | +25.8% |
| 17 | Eversept Partners, LP | 1.0M | $32.8M | 1.8% | 0.9% | +66.9% |
| 18 | AMERIPRISE FINANCIAL INC | 967,621 | $31.5M | 0.0% | 0.8% | -55.1% |
| 19 | GOLDMAN SACHS GROUP INC | 876,904 | $28.6M | 0.0% | 0.7% | -7.0% |
| 20 | BARCLAYS PLC | 872,696 | $28.4M | 0.0% | 0.7% | +1546.9% |
| 21 | BANK OF AMERICA CORP /DE/ | 863,951 | $28.2M | 0.0% | 0.7% | +125.1% |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 846,572 | $27.6M | 0.0% | 0.7% | +15.9% |
| 23 | RAYMOND JAMES FINANCIAL INC | 829,042 | $27.0M | 0.0% | 0.7% | +4.3% |
| 24 | D. E. Shaw & Co., Inc. | 820,058 | $26.7M | 0.0% | 0.7% | -48.9% |
| 25 | VANGUARD FIDUCIARY TRUST CO | 790,004 | $25.8M | 0.0% | 0.7% | +7.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.